netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 9 of 9


Details
LDL Link Added : MHRA Drug Safety Update (June 2021): CDK4/6 inhibitors : https://www.gov.uk/drug-safety-update/cdk4-slash-6-inhibitors-abemaciclibv-palbociclibv-ribociclibv-reports-of-interstitial-lung-disease-and-pneumonitis-including-severe-cases
30/06/2023 15:47:11
(rpaylor )
LDL Link Added : NICE TA810: Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence : https://www.nice.org.uk/guidance/ta810
30/06/2023 15:46:38
(rpaylor )
LDL Link Added : NICE TA725: Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy : https://www.nice.org.uk/guidance/ta725
16/12/2021 15:30:44
(DavidS )
UPD sitematrix Changed from 0 to
16/12/2021 15:30:22
(DavidS )
UPD FurtherInformation Changed from
16/12/2021 15:30:22
(DavidS )
UPD Abemaciclib (Verzenios®) NICE TA725
16/12/2021 15:30:22
(DavidS )
UPD Abemaciclib Published from Draft Mode
30/05/2019 15:39:50
(DavidS )
LDL Link Added : NICE TA 563: Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer : https://www.nice.org.uk/guidance/ta563
25/04/2019 13:09:20
(DavidS )
ADD Abemaciclib (Verzenios®) added NICE TA563
25/04/2019 13:00:12
(DavidS )

 

 
netFormulary